Original research
par
van Santen, Daniela K. et al
Date de publication
2023
Géographie
International
Langue de la ressource
English
Texte disponible en version intégrale
Oui
Open Access / OK to Reproduce
Oui
Évalué par des pairs
Yes
L’objectif
We measured the pooled effect of needle and syringe program (NSP) and opioid agonist therapy (OAT) participation on HIV and HCV incidence in the Netherlands, Canada and Australia.
Constatations/points à retenir
In the Netherlands, Canada and Australia, comprehensive needle and syringe program and opioid agonist therapy participation appears to substantially reduce HIV and hepatitis C acquisition compared with no or partial needle and syringe program/opioid agonist therapy participation
La conception ou méthodologie de recherche
For each cohort, we emulated the design and statistical analysis of a target trial using observational data
Mots clés
Harm reduction
Substitution/OAT
Wrap-around services
About PWUD
